Lessons from a large nationwide cohort of 350 children with ovarian mature teratoma: A study in favor of ovarian-sparing surgery.
Fanny DelehayeSabine SarnackiDaniel OrbachAlaa CheikhelardJérémie RougerJean-Jacques ParientiCecile Faure ConterFrédéric HameuryFrédérique DijoudEstelle AubryAgnès WacrenierEdouard HabonimanaCamille DuchesneSolène JosephHortense AlliotAurélien ScalabreYann ChaussyGuillaume PodevinAnne CroueElodie HarauxMarie Pierre GuibalIsabelle PommepuyQuentin BallouheyFrédéric LavrandMatthieu PeycelonSabine IrtanFlorent GuérinAnne DarielClaude BorionneLouise GalmicheJulien RodPublished in: Pediatric blood & cancer (2021)
This study is a plea in favor of OSS as the first-choice treatment of OMT when possible. Close follow-up during the first 5 years is mandatory considering the risk of 8.3% of second events, especially in cases with risk factors.